RPS23P7

Across TCGA pan-cancer cohorts, RPS23P7 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPS23P7 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RPS23P7 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPS23P7 expression acts as an unfavorable survival marker, although some lineages such as HNSC and COAD show a favorable association.

HNSC, KIRC, and KIRP are the cancer types where RPS23P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	IV	0.505	0.344	.004	111	view →
KIRC	OS	Quartile	II,III,IV	0.561	0.751	<.001	90	view →
KIRP	DFS	Tertile	All	0.400	0.663	.001	37	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
COAD	OS	Quartile	All	0.746	0.495	.004	34	view →
OV	DFS	Quartile	All	0.114	0.224	.006	32	view →
UCS	DFS	Median	All	0.336	0.616	.003	30	view →
STAD	OS	Quartile	II,III,IV	0.562	0.732	.014	29	view →
SARC	OS	Tertile	All	0.353	0.550	.002	27	view →
MESO	DFS	Tertile	All	0.671	0.350	.034	24	view →
ESCA	OS	Tertile	IV	0.738	0.238	.024	15	view →
THYM	DFS	Tertile	All	0.532	0.897	<.001	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RPS23P7–HNSC (OS)

Open the HNSC breakdown →